Michael J. Farrell
Private Equity Investor at Deerfield Management Co. LP (Private Equity)
Profile
Michael Farrell is a Principal on the External Operations team.
Mr. Farrell joined the Firm in 2016 as an Operations Executive, supporting the day-to-day oversight and management of investments in the Firm’s Private Design and Healthcare Innovations Funds.
Prior to Deerfield, Mr. Farrell was Vice President of Finance at Amarin Corporation, a publicly traded biopharmaceutical company.
Before Amarin, he was Controller at Unigene Laboratories, New American Therapeutics, and Akrimax Pharmaceuticals, and served as Director of Accounting at Reliant Pharmaceuticals.
Mr. Farrell began his career in the financial statement audit practice at Arthur Andersen, during which time he became a Certified Public Accountant.
Mr. Farrell holds a B.S.
in Accounting from the University of Maryland.
Michael J. Farrell active positions
Companies | Position | Start |
---|---|---|
Deerfield Management Co. LP (Private Equity)
Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management Co. LP (Private Equity) (Deerfield) is a private equity subsidiary of Deerfield Management Co. LP founded in 1994. The firm is headquartered in the New York. | Private Equity Investor | 2016-02-29 |
Former positions of Michael J. Farrell
Companies | Position | End |
---|---|---|
AMARIN CORPORATION PLC | Director of Finance/CFO | 2016-06-29 |
UNIGENE LABORATORIES INC | Comptroller/Controller/Auditor | 2013-05-31 |
New American Therapeutics, Inc.
New American Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology New American Therapeutics, Inc. is a pharmaceutical company, which acquires, markets and develops products in cardiovascular area. The company is headquartered in Parsippany, NJ. | Comptroller/Controller/Auditor | 2012-03-31 |
Akrimax Pharmaceuticals LLC
Akrimax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Akrimax Pharmaceuticals LLC manufactures medicines for metabolic syndrome. The company's products include Inderal and Lo/Ovral. The company was founded in 2007 by Joseph J. Krivulka and Leonard L. Mazur and is headquartered in Cranford, NJ | Comptroller/Controller/Auditor | 2010-08-31 |
Training of Michael J. Farrell
University of Maryland | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
AMARIN CORPORATION PLC | Health Technology |
Private companies | 4 |
---|---|
Unigene Laboratories, Inc.
Unigene Laboratories, Inc. Pharmaceuticals: OtherHealth Technology Unigene Laboratories, Inc. was a biopharmaceutical company, which engaged in the designing, delivering, manufacturing and development of peptide-based therapeutics. The company was founded by Jay Levy, Ronald S. Levy and Warren P. Levy on October 31, 1980 and was headquartered in Boonton, NJ. | Health Technology |
New American Therapeutics, Inc.
New American Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology New American Therapeutics, Inc. is a pharmaceutical company, which acquires, markets and develops products in cardiovascular area. The company is headquartered in Parsippany, NJ. | Health Technology |
Akrimax Pharmaceuticals LLC
Akrimax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Akrimax Pharmaceuticals LLC manufactures medicines for metabolic syndrome. The company's products include Inderal and Lo/Ovral. The company was founded in 2007 by Joseph J. Krivulka and Leonard L. Mazur and is headquartered in Cranford, NJ | Health Technology |
Deerfield Management Co. LP (Private Equity)
Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management Co. LP (Private Equity) (Deerfield) is a private equity subsidiary of Deerfield Management Co. LP founded in 1994. The firm is headquartered in the New York. | Finance |
- Stock Market
- Insiders
- Michael J. Farrell